Immunostimulating capacities of stabilized RNA molecules
- 3 February 2004
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 34 (2) , 537-547
- https://doi.org/10.1002/eji.200324198
Abstract
Since direct injection of naked mRNA induces an immune response, we tested the capacity of RNA to signal danger. We show here that mRNA molecules that are protected from immediate degradation either through interaction with cationic proteins (trans protection) or through chemical modification of the phosphodiester backbone (phosphorothioate RNA; cis protection) act as sequence-independent danger signals on mouse DC. As opposed to CpG DNA, the cis-stabilized RNA is degraded in a few minutes, does not activate B cells and, in contrast to double-stranded RNA, requires MyD88 for activation of the DC. We postulate that phosphorothioate RNA, which mimics trans-stabilized RNA, is a new PAMP.Keywords
This publication has 37 references indexed in Scilit:
- Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyEuropean Journal of Immunology, 2002
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848Nature Immunology, 2002
- The Danger Model: A Renewed Sense of SelfScience, 2002
- Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine ModelInfection and Immunity, 2002
- Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 2002
- Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Induction of Anti-Tumor Immunity with Epidermal Cells Pulsed with Tumor-Derived RNA or Intradermal Administration of RNAJournal of Investigative Dermatology, 2000
- CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvantsEuropean Journal of Immunology, 1997
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Naturally‐occurring double‐stranded RNA and immune responses. IV. Influence of molecular size on antigenicity and adjuvant activityEuropean Journal of Immunology, 1976